Editorial: restoring therapeutic infliximab drug levels in patients with loss of response—pharmacokinetics and anti‐drug antibodies as useful guidance tools

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|47|6|845-846

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.47, Iss.6, 2018-03, pp. : 845-846

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Letter: addition of azathioprine to infliximab maintenance therapy in patients with anti‐drug antibodies and subclinical inflammation

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 4, 2018-02 ,pp. : 544-545

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug concentration and antidrug antibodies in patients with psoriasis treated with adalimumab or etanercept

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 31, Iss. 12, 2017-12 ,pp. : e518-e519

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Utility of Random Anti–Tumor Necrosis Factor Drug–Level Testing and Measurement of Antidrug Antibodies on the Long‐Term Treatment Response in Rheumatoid Arthritis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 8, 2015-05 ,pp. : 2011-2019

John Wiley & Sons Inc

Access to resources Recommend Favorite

Age‐Related Therapeutic Response to Antithyroid Drug in Patients with Hyperthyroid Graves' Disease

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 42, Iss. 5, 1994-05 ,pp. : 513-516

John Wiley & Sons Inc

Access to resources Recommend Favorite

The correlation of clinical efficacy, serum trough levels and antidrug antibodies in ustekinumab‐treated patients with psoriasis in a clinical‐practice setting

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 7-0963, Iss. 3, 2015-09 ,pp. : 855-857

John Wiley & Sons Inc

Access to resources Recommend Favorite